Table 4. Therapeutic Classes for Initial Use Patients Initiated on a Fixed-Dose Combination (FDC) or Free-Equivalent Combination (FEC)
Therapeutic classFDC (n = 795)FEC (n = 712)
ACEI and thiazide397 (49.9)187 (26.3)
ARB and thiazide250 (31.5)39 (5.5)
ACEI and CCB83 (10.4)80 (11.2)
ACEI and β-blocker0 (0)140 (19.7)
β-Blocker and thiazide34 (4.3)81 (11.4)
CCB and thiazide0 (0)73 (10.3)
ARB and CCB31 (3.9)28 (3.9)
β-Blocker and CCB0 (0)38 (5.3)
ARB and β-blocker0 (0)34 (4.8)
ACEI and ARB0 (0)12 (1.7)
  • Data are number (%).

  • ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; β-blocker, cardioselective β-blocker; CCB, calcium channel blocker; thiazide, thiazide and thiazide-like diuretics.